| Code | CSB-MP007403HU |
| Abbreviation | Recombinant Human EDNRA protein-VLPs (Active) |
| MSDS | |
| Size | $558 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Endothelin-1 receptor type A mediates vasoconstriction and smooth muscle proliferation in cardiovascular physiology, making it a critical target for hypertension and heart failure research. This full-length mature protein (aa 21–427) is presented in virus-like particles that preserve native membrane topology and conformational epitopes, enabling functional antibody binding assays with an EC50 of 2.225–3.570 ng/mL when tested against a recombinant anti-EDNRA antibody in ELISA format. The quantified binding activity supports use in competitive inhibition screens, therapeutic antibody epitope mapping, and blocking antibody validation studies where receptor conformation directly influences epitope accessibility. Endotoxin levels below 1.0 EU/μg align with standards expected in cell-based assays and antibody characterization workflows that require low inflammatory background.
There are currently no reviews for this product.